Global Gene Therapy Products Market Research Report 2021

1 Gene Therapy Products Market Overview

• 1.1 Product Overview and Scope of Gene Therapy Products
• 1.2 Gene Therapy Products Segment by Type
  • 1.2.1 Global Gene Therapy Products Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Ex vivo
  • 1.2.3 In Vivo
• 1.3 Gene Therapy Products Segment by Application
  • 1.3.1 Global Gene Therapy Products Sales Comparison by Application: (2021-2027)
  • 1.3.2 Cancer
  • 1.3.3 Monogenic
  • 1.3.4 Infectious disease
  • 1.3.5 Cardiovascular disease
  • 1.3.6 Other
• 1.4 Global Gene Therapy Products Market Size Estimates and Forecasts
  • 1.4.1 Global Gene Therapy Products Revenue 2016-2027
  • 1.4.2 Global Gene Therapy Products Sales 2016-2027
  • 1.4.3 Gene Therapy Products Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gene Therapy Products Market Competition by Manufacturers

• 2.1 Global Gene Therapy Products Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Gene Therapy Products Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Gene Therapy Products Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Gene Therapy Products Manufacturing Sites, Area Served, Product Type
• 2.5 Gene Therapy Products Market Competitive Situation and Trends
  • 2.5.1 Gene Therapy Products Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Gene Therapy Products Players Market Share by Revenue
  • 2.5.3 Global Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gene Therapy Products Retrospective Market Scenario by Region

• 3.1 Global Gene Therapy Products Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Gene Therapy Products Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Gene Therapy Products Market Facts & Figures by Country
  • 3.3.1 North America Gene Therapy Products Sales by Country
  • 3.3.2 North America Gene Therapy Products Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Gene Therapy Products Market Facts & Figures by Country
  • 3.4.1 Europe Gene Therapy Products Sales by Country
  • 3.4.2 Europe Gene Therapy Products Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Gene Therapy Products Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Gene Therapy Products Sales by Region
  • 3.5.2 Asia Pacific Gene Therapy Products Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Gene Therapy Products Market Facts & Figures by Country
  • 3.6.1 Latin America Gene Therapy Products Sales by Country
  • 3.6.2 Latin America Gene Therapy Products Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Gene Therapy Products Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Gene Therapy Products Sales by Country
  • 3.7.2 Middle East and Africa Gene Therapy Products Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Gene Therapy Products Historic Market Analysis by Type

• 4.1 Global Gene Therapy Products Sales Market Share by Type (2016-2021)
• 4.2 Global Gene Therapy Products Revenue Market Share by Type (2016-2021)
• 4.3 Global Gene Therapy Products Price by Type (2016-2021)

5 Global Gene Therapy Products Historic Market Analysis by Application

• 5.1 Global Gene Therapy Products Sales Market Share by Application (2016-2021)
• 5.2 Global Gene Therapy Products Revenue Market Share by Application (2016-2021)
• 5.3 Global Gene Therapy Products Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Bluebird Bio
  • 6.1.1 Bluebird Bio Corporation Information
  • 6.1.2 Bluebird Bio Description and Business Overview
  • 6.1.3 Bluebird Bio Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Bluebird Bio Gene Therapy Products Product Portfolio
  • 6.1.5 Bluebird Bio Recent Developments/Updates
• 6.2 Sangamo
  • 6.2.1 Sangamo Corporation Information
  • 6.2.2 Sangamo Description and Business Overview
  • 6.2.3 Sangamo Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Sangamo Gene Therapy Products Product Portfolio
  • 6.2.5 Sangamo Recent Developments/Updates
• 6.3 Spark Therapeutics
  • 6.3.1 Spark Therapeutics Corporation Information
  • 6.3.2 Spark Therapeutics Description and Business Overview
  • 6.3.3 Spark Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Spark Therapeutics Gene Therapy Products Product Portfolio
  • 6.3.5 Spark Therapeutics Recent Developments/Updates
• 6.4 Dimension Therapeutics
  • 6.4.1 Dimension Therapeutics Corporation Information
  • 6.4.2 Dimension Therapeutics Description and Business Overview
  • 6.4.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Dimension Therapeutics Gene Therapy Products Product Portfolio
  • 6.4.5 Dimension Therapeutics Recent Developments/Updates
• 6.5 Avalanche Bio
  • 6.5.1 Avalanche Bio Corporation Information
  • 6.5.2 Avalanche Bio Description and Business Overview
  • 6.5.3 Avalanche Bio Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Avalanche Bio Gene Therapy Products Product Portfolio
  • 6.5.5 Avalanche Bio Recent Developments/Updates
• 6.6 Celladon
  • 6.6.1 Celladon Corporation Information
  • 6.6.2 Celladon Description and Business Overview
  • 6.6.3 Celladon Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Celladon Gene Therapy Products Product Portfolio
  • 6.6.5 Celladon Recent Developments/Updates
• 6.7 Vical Inc.
  • 6.6.1 Vical Inc. Corporation Information
  • 6.6.2 Vical Inc. Description and Business Overview
  • 6.6.3 Vical Inc. Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Vical Inc. Gene Therapy Products Product Portfolio
  • 6.7.5 Vical Inc. Recent Developments/Updates
• 6.8 Advantagene
  • 6.8.1 Advantagene Corporation Information
  • 6.8.2 Advantagene Description and Business Overview
  • 6.8.3 Advantagene Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Advantagene Gene Therapy Products Product Portfolio
  • 6.8.5 Advantagene Recent Developments/Updates

7 Gene Therapy Products Manufacturing Cost Analysis

• 7.1 Gene Therapy Products Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Gene Therapy Products
• 7.4 Gene Therapy Products Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Gene Therapy Products Distributors List
• 8.3 Gene Therapy Products Customers

9 Gene Therapy Products Market Dynamics

• 9.1 Gene Therapy Products Industry Trends
• 9.2 Gene Therapy Products Growth Drivers
• 9.3 Gene Therapy Products Market Challenges
• 9.4 Gene Therapy Products Market Restraints

10 Global Market Forecast

• 10.1 Gene Therapy Products Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Gene Therapy Products by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Gene Therapy Products by Type (2022-2027)
• 10.2 Gene Therapy Products Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Gene Therapy Products by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Gene Therapy Products by Application (2022-2027)
• 10.3 Gene Therapy Products Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Gene Therapy Products by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Gene Therapy Products by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List